Bharat Biotech submits additional data to WHO, decision on Covaxin EUL likely on November 3 https://ift.tt/31eNk1s

The Technical Advisory Group (TAG), an independent advisory panel of the World Health Organisation (WHO), has sought additional clarifications from Bharat Biotech, the manufacturer of Covaxin, in order to conduct a final Emergency Use Listing (EUL) risk-benefit assessment for global use of the vaccine.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3k0j94O